Endometriosis May Be Promoted by Midkine: Possible Involvement of Ovarian Follicles

In: Midkine: From Embryogenesis to Pathogenesis and Therapy · 2012 · pp. 195–202 · doi:10.1007/978-94-007-4234-5_17 · W116840266
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-12

Midkine, present in ovarian follicular fluid, stimulates endometriotic stromal cell proliferation and is elevated in peritoneal fluid of women with advanced endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

The paper examined the role of midkine, a heparin-binding cytokine, as a potential local ovarian-derived factor in endometriosis by comparing its concentrations in ovarian follicular fluid versus peritoneal fluid and assessing effects on endometriotic stromal cells. The authors report that midkine is relatively high in follicular fluid (>200 ng/ml) but low in peritoneal fluid (~1 ng/ml), with peritoneal levels increasing after ovulation, consistent with follicular fluid midkine being released at that time. They further find that midkine at concentrations >100 ng/ml stimulates proliferation of endometriotic stromal cells and that peritoneal midkine levels are higher in women with advanced endometriosis than in those with no or minimal disease, while noting these observations are presented as plausible rather than definitive. This paper is centrally about endometriosis — it proposes midkine from ovarian follicular fluid as a promoter of lesion growth and elevated peritoneal levels in advanced disease.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,412 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Endometriosis is an enigmatic disease, the etiology of which is poorly understood. The lesion of endometriosis is preferentially located in the peritoneum around the ovary. We therefore speculated that some local factor derived from the ovary is involved in the development of endometriosis. Relatively high concentrations (higher than 200 ng/ml) of midkine are detected in follicular fluids in the ovary, implying its roles in the follicular growth. In contrast, concentrations of midkine in peritoneal fluid are around 1 ng/ml. Midkine concentrations in peritoneal fluid increase after ovulation, suggesting that midkine in follicular fluid erupting at ovulation contribute to the concentrations in peritoneal fluid. Interestingly, midkine (higher than 100 ng/ml) stimulates the proliferation of endometriotic stromal cells. Therefore, it is plausible that endometriotic lesions are stimulated to grow by directly exposed to midkine in follicular fluid at the time of ovulation. In addition, midkine concentrations in peritoneal fluid are higher in women with advanced endometriosis compared to those with no or minimal endometriosis, further suggesting the involvement of MK in endometriosis. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

References

Muramatsu T (2010) Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 86:410–425 Chung HW, Wen Y, Choi EA et al (2002) Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. Mol Hum Reprod 8:350–355 Giudice LC (2010) Endometriosis. N Engl J Med 362:2389–2398 Osuga Y (2008) Novel therapeutic strategies for endometriosis: a pathophysiological perspective. Gynecol Obstet Invest 66(Suppl 1):3–9 Osuga Y, Koga K, Hirota Y et al (2010) Lymphocytes in endometriosis. Am J Reprod Immunol 65:1–10 Ohyama Y, Miyamoto K, Minamino N et al (1994) Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol Cell Endocrinol 105:203–208 Karino S, Minegishi T, Ohyama Y et al (1995) Regulation and localization of midkine in rat ovary. FEBS Lett 362:147–150 Minegishi T, Karino S, Tano M et al (1996) Regulation of midkine messenger ribonucleic acid levels in cultured rat granulosa cells. Biochem Biophys Res Commun 229:799–805 Hirota Y, Osuga Y, Nose E et al (2007) The presence of midkine and its possible implication in human ovarian follicles. Am J Reprod Immunol 58:367–373 Hirota Y, Osuga Y, Koga K et al (2005) Possible implication of midkine in the development of endometriosis. Hum Reprod 20:1084–1089 Arimoto T, Katagiri T, Oda K et al (2003) Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis. Int J Oncol 22:551–560 Inoh K, Muramatsu H, Ochiai K et al (2004) Midkine, a heparin-binding cytokine, plays key roles in intraperitoneal adhesions. Biochem Biophys Res Commun 317:108–113 Bahtiyar MO, Seli E, Oral E et al (1998) Follicular fluid of women with endometriosis stimulates the proliferation of endometrial stromal cells. Hum Reprod 13:3492–3495 Frederick JL, Shimanuki T, diZerega GS (1984) Initiation of angiogenesis by human follicular fluid. Science 224:389–390 Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Additional information Funding: This study is partly supported by grants from the Ministry of Health, Labour and Welfare, and the Ministry of Education, Culture, Sports, Science and Technology. Conflict of interest: The authors have no conflict of interest. Rights and permissions Copyright information © 2012 Springer Science+Business Media B.V. About this chapter Cite this chapter Osuga, Y., Hirota, Y., Koga, K., Yoshino, O., Hirata, T. (2012). Endometriosis May Be Promoted by Midkine: Possible Involvement of Ovarian Follicles. In: Ergüven, M., Muramatsu, T., Bilir, A. (eds) Midkine: From Embryogenesis to Pathogenesis and Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4234-5_17 Download citation DOI: https://doi.org/10.1007/978-94-007-4234-5_17 Published: Publisher Name: Springer, Dordrecht Print ISBN: 978-94-007-4233-8 Online ISBN: 978-94-007-4234-5 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK